Оne of the largest medicine manufacturers in Russia, Binnopharm Group was created in 2020 through consolidation of pharmaceutical assets of Sistema. The Group boasts five plants, which produce an extensive range of prescription and OTC medicines.
The Group has over 450 marketing authorisations in Russia, more than 100 medicines included in in the List of Vital and Essential Medicines. With five plants across Russia, Binnopharm Group has the largest area of medicine production capacity in Russia. Binnopharm Group facilities manufacture medicines in all dosage forms, from tablets and capsules to sprays, injections, and suppositories. 20% of the products are made from the Group’s own active pharmaceutical ingredients.
Binnopharm Group medicines are procured under government tenders, sold in the retail pharmaceutical market, and also exported to 14 countries worldwide. The Group is one of the largest suppliers for the inpatient segment, providing clinics and hospitals with antibiotics in various dosage forms; medicines for endocrinology, neurology, cardiology and other therapeutic groups; and medical devices for blood transfusion.
Binnopharm Group makes high-quality, effective and safe medical products and adhering to GMP standards.
The Group’s products are also available in 14 countries. Official representative offices of Binnopharm Group have been opened in 6 CIS countries and China.
Binnopharm Group constantly develops new products and expands its portfolio. In 2023 the Group opens an advanced R&D center in Russia, with a total floor area of 12,000 sq m. By 2025, Binnopharm Group is set to market over 100 medical products for such disease areas as dermatology, neurology, gynaecology, paediatrics, etc.
Human capital development along with constant upgrades of production capacities, improvement of R&D competencies, and adherence to the world's top quality control standards is what underpins Binnopharm Group’s operations.
Company Details
- Employees
- 103
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.binnopharmgroup.ru/
Binnopharm Group Questions
Binnopharm Group's website is https://www.binnopharmgroup.ru/
Binnopharm Group's LinkedIn profile is https://www.linkedin.com/company/binnopharm-group
Binnopharm Group has
103 employees.
View email and phone details for 103
employees at Binnopharm Group.
Binnopharm Group's industry is
Pharmaceutical Manufacturing
Binnopharm Group's top competitors are
Solopharm,
Rus Biopharm,
Petrovax Pharm,
R-Pharm,
Generium,
Geropharm,
Valenta Pharmaceuticals,
Biocad,
Pharmasyntez Group Of Companies,
Nanolek.
Binnopharm Group's categories are Pharmaceutical Manufacturing
Binnopharm Group's founding year is 2020
